Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology
Link
http://www.nature.com/articles/s41541-020-0209-2.pdf
Reference21 articles.
1. Wu, R. et al. An update on current therapeutic drugs treating COVID-19. Curr. Pharmacol. Rep. 6, 56–70 (2020).
2. Wu, F. et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv. https://doi.org/10.1101/2020.03.30.2004736 (2020).
3. Liu, S. T. H. et al. Convalescent plasma treatment of severe COVID-19: a matched control study. medRxiv. https://doi.org/10.1101/2020.03.30.20047365 (2020).
4. Kim, J., Hayton, W. L., Robinson, J. M. & Anderson, C. L. Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model. Clin. Immunol. 122, 146–155 (2007).
5. Bihl, F., Castelli, D., Marincola, F., Dodd, R. Y. & Brander, C. Transfusion-transmitted infections. J. Transl. Med. 5, 25 (2007).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. COVID-19 ethics: unique aspects and a review as of early 2024;Monash Bioethics Review;2024-06
2. Plasma-Derived Medicinal Products in Nigeria;SN Comprehensive Clinical Medicine;2023-08-03
3. Intravenous immunoglobulin and convalescent plasma treatment in the COVID-19 patient;Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination;2023
4. Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis;Frontiers in Public Health;2022-07-22
5. The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis;Frontiers in Medicine;2021-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3